Iva Jean Bolman, LPN | |
601 Gall St., Lower Brule, SD 57548 | |
(605) 473-0852 | |
Not Available |
Full Name | Iva Jean Bolman |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 601 Gall St., Lower Brule, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336328574 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 003859 (South Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Iva Jean Bolman, LPN Box 18, Rr 8 Hc5, Reliance, SD 57369 Ph: (605) 473-0852 | Iva Jean Bolman, LPN 601 Gall St., Lower Brule, SD 57548 Ph: (605) 473-0852 |
News Archive
Brain imaging can offer a window into risk for diseases such as Alzheimer's disease (AD). A study conducted at the University of Kansas School of Medicine demonstrated that genetic risk is expressed in the brains of even those who are healthy, but carry some risk for AD. The results of this study are published in the November 2009 issue of the Journal of Alzheimer's Disease.
A new study to be presented at the American Association for the Advancement of Science (AAAS) in February 2020 will report on the generation of the world's first artificially created bacterial genome using a digital design algorithm along with the synthesis of DNA building blocks on a large scale. This genome takes form by chemical rather than template-based synthesis. The research is published in the journal Proceedings of the National Academy of Sciences.
A bird flu scare in South Korea has prompted Japan to ban all imports of poultry from there.
This post in the Center for Global Health Policy's "Science Speaks" blog reports on a presentation at the Union World Conference on Lung Health in France on Saturday by Evelyne Kibuchi, a senior tuberculosis (TB) advocacy officer at the Kenya AIDS NGOs Consortium (KANCO), writing, "HIV stakeholders have been slow to embrace and adopt TB interventions, Kibuchi said, and resources for co-infection activities are modest.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB's sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Sodium oxybate has demonstrated robust efficacy in Phase III clinical trials for fibromyalgia and interviewed thought leaders are impressed with its effect on several key symptom domains of fibromyalgia, which include pain, sleep and fatigue.
› Verified 5 days ago
Desiree Nolene Laroche, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 601 Gall St., Lower Brule, SD 57548 Phone: 605-473-5526 Fax: 605-473-5677 | |
Miss Georgia Wilson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 601 Gall St., Lower Brule, SD 57548 Phone: 605-473-8243 Fax: 605-473-0607 |